Bridgeway Capital Management’s Cognition Therapeutics CGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-31,874
| Closed | -$22.4K | – | 1189 |
|
|
2024
Q4 | $22.4K | Sell |
31,874
-44,826
| -58% | -$31.4K | ﹤0.01% | 1182 |
|
|
2024
Q3 | $35.9K | Hold |
76,700
| – | – | ﹤0.01% | 1231 |
|
|
2024
Q2 | $127K | Hold |
76,700
| – | – | ﹤0.01% | 1137 |
|
|
2024
Q1 | $140K | Sell |
76,700
-14,500
| -16% | -$26.4K | ﹤0.01% | 1168 |
|
|
2023
Q4 | $169K | Buy |
91,200
+25,000
| +38% | +$46.3K | ﹤0.01% | 1170 |
|
|
2023
Q3 | $95.3K | Hold |
66,200
| – | – | ﹤0.01% | 1238 |
|
|
2023
Q2 | $121K | Hold |
66,200
| – | – | ﹤0.01% | 1227 |
|
|
2023
Q1 | $131K | Hold |
66,200
| – | – | ﹤0.01% | 1183 |
|
|
2022
Q4 | $139K | Hold |
66,200
| – | – | ﹤0.01% | 1166 |
|
|
2022
Q3 | $126K | Hold |
66,200
| – | – | ﹤0.01% | 1232 |
|
|
2022
Q2 | $141K | Sell |
66,200
-10,000
| -13% | -$21.3K | ﹤0.01% | 1160 |
|
|
2022
Q1 | $206K | Buy |
+76,200
| New | +$206K | ﹤0.01% | 1168 |
|